CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis

Recruiting now · Not applicable

Conditions studied: Atopic Dermatitis (AD)

In brief

This is an open-label, randomised, comparative, prospective, interventional study of a cosmetic product.

Key facts

Study ID

NCT07204561

Run by

Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse

People needed

98

Starts

2025-03-25

Expected to finish

2026-07-01

Last updated by the study team

2025-10-02

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with clinically confirmed mild-to-moderate atopic dermatitis (AD), as defined by an Eczema Area and Severity Index (EASI) score of 1-21, whose lesions will clear after treatment with a steroid and who will experience at least a 90% reduction in their EASI score.
• Participants of any gender, aged 18 years or over, from any phototype or ethnic group.
• Participants must be willing and able to give informed consent to participate in the study.

You may not qualify if…

• Age <18 years. Participants who are unwilling or unable to give informed consent to participate in the study.
• Receiving any systemic treatment for atopic dermatitis (AD), including corticosteroids, cyclosporine, any approved biologics or JAK inhibitors.
• Any dermatological disorder which, in the investigator's opinion, may interfere with the accurate evaluation of the subject's skin characteristics (except AD).

Where it is running

• Fondazione PTV - Policlinico Tor Vergata — Roma, RM, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.